BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6364766)

  • 21. Ventricular fibrillation.
    Surawicz B
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):43B-54B. PubMed ID: 3889113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic actions of BRB-I-28 in ischemically injured canine myocardium.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):637-46. PubMed ID: 7681911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the mechanism of action of antiarrhythmic agents.
    Grant AO
    Am Heart J; 1992 Apr; 123(4 Pt 2):1130-6. PubMed ID: 1313200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiologic mechanisms of cardiac arrhythmias.
    Wit AL; Rosen MR
    Am Heart J; 1983 Oct; 106(4 Pt 2):798-811. PubMed ID: 6310978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between ventricular arrhythmias and ischemia-induced conduction delay in closed-chest animals within 24 hours of myocardial infarction.
    Fujimoto T; Peter T; Katoh T; Hamamoto H; Mandel WJ
    Am Heart J; 1984 Feb; 107(2):201-9. PubMed ID: 6695653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cardiac vulnerable period and reentrant arrhythmias: targets of anti- and proarrhythmic processes.
    Starmer CF
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):445-54. PubMed ID: 9058848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New directions in the development of antiarrhythmic drugs.
    Miura DS; Rosen MR
    J Clin Pharmacol; 1984 Jul; 24(7):333-41. PubMed ID: 6090508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologic effects of coronary occlusion and reperfusion. Observations of dispersion of refractoriness and ventricular automaticity.
    Levites R; Banka VS; Helfant RH
    Circulation; 1975 Nov; 52(5):760-5. PubMed ID: 1175258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mode of action of antiarrhythmic drugs and the implicated arrhythmogenic risk.
    Davy JM; Sirinelli A; Le Guludec D; Sebag C; Motté G
    Eur Heart J; 1988 Feb; 9 Suppl B():5-12. PubMed ID: 3286267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H; Weirich J
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative investigations on the antiarrhythmic and electrophysiologic effects of class I-IV antiarrhythmic agents following acute coronary artery occlusion.
    Thale J; Haverkamp W; Hindricks G; Gülker H
    Eur Heart J; 1987 Oct; 8 Suppl G():91-8. PubMed ID: 3443133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New aspects of the molecular effect of anti-arrhythmia agents].
    Honerjäger P
    Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of calcium antagonists for cardiac arrhythmias.
    Singh BN; Nademanee K
    Am J Cardiol; 1987 Jan; 59(3):153B-162B. PubMed ID: 2433930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of cardiac arrhythmias by calcium antagonism.
    Nademanee K; Singh BN
    Ann N Y Acad Sci; 1988; 522():536-52. PubMed ID: 3288060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of the electrophysiologic matrix by antiarrhythmic drugs.
    Hoffman BF
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):28B-30B. PubMed ID: 3923078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of class I anti-arrhythmic drugs in infarcted tissue.
    Man RY; Bril A
    Clin Invest Med; 1991 Oct; 14(5):466-75. PubMed ID: 1742923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lidocaine does not affect myocardial electrical heterogeneity: implications for low proarrhythmic actions.
    Sims JJ; Winecoff AP; Ujhelyi MR
    Pharmacotherapy; 1997; 17(6):1267-73. PubMed ID: 9399610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model.
    Kaplinsky E; Ogawa S; Balke CW; Dreifus LS
    Circulation; 1979 Aug; 60(2):397-403. PubMed ID: 445757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
    Das B; Sarkar C
    Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.